Professor Kari Alitalo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Professor kari alitalo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Professor Kari Alitalo Today - Breaking & Trending Today

New academic spin-out based in Finland introduces a nasal spray vaccine against COVID


New academic spin-out based in Finland introduces a nasal spray vaccine against COVID
Mar 8 2021
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland.
Image Credit: University of Eastern Finland
The vaccine uses gene transfer technology developed at the University of Eastern Finland by Academy Professor Seppo Ylä-Herttuala s research group, and the technology has already been successfully used in several clinical trials using gene therapy to treat cardiovascular diseases and cancer. ....

Eteläuomen Läi , South Africa , Norra Savolax , United Kingdom , Landskapet Birkaland , South African , Kari Alitalo , Seppo Yl , Emily Henderson , University Of Helsinki , Academy Professor , Rokote Laboratories Finland Ltd , Academy Professor Seppo Yl , University Of Eastern Finland , Laboratories Finland Ltd , Eastern Finland , Virology Kalle Saksela , Rokote Laboratories Finland , Professor Kalle Saksela , Professor Kari Alitalo , Gene Therapy , Gene Transfer , Nasal Spray , ஒன்றுபட்டது கிஂக்டம் , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் ஆஃப் ஹெல்சின்கி ,

University of Helsinki and University of Eastern Finland shareholders in a Finnish COVID vaccine company


Date Time
University of Helsinki and University of Eastern Finland shareholders in a Finnish COVID vaccine company
Rokote Laboratories Finland Ltd., is a newly-founded, Finnish academic spin-out working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland.
The founders and board members of the company are the vaccine developers Academy Professor Seppo Ylä-Herttuala from the University of Eastern Finland, Professor Kalle Saksela and Professor Kari Alitalo from the University of Helsinki, and Mr Pasi Kemppainen, MSc (Techn.). The University of Helsinki and the University of Eastern Finland are also co-founders of, and shareholders in, the company. ....

Norra Savolax , United Kingdom , South Africa , Eteläuomen Läi , Landskapet Birkaland , South African , Kari Alitalo , University Of Helsinki , Rokote Laboratories Finland Ltd , Academy Professor Seppo Yl , University Of Eastern Finland , Academy Professor Yl , University Of Helsinki Paula Eerola , Academy Of Finland , Rector Of The University Eastern Finland , Eastern Finland , Professor Kalle Saksela , Professor Kari Alitalo , Helsinki Paula Eerola , Rokote Laboratories Finland , Virology Kalle Saksela , Immune Response , Clinical Trials , Gene Therapy , ஒன்றுபட்டது கிஂக்டம் , பல்கலைக்கழகம் ஆஃப் ஹெல்சின்கி ,

Finnish researchers introduce a nasal COVID vaccine


Finnish researchers introduce a nasal COVID vaccine
News provided by
Share this article
JOENSUU, Finland, March 8, 2021 /PRNewswire/
Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland.
The vaccine uses gene transfer technology developed at the University of Eastern Finland by Academy Professor
Seppo Ylä-Herttuala s research group, and the technology has already been successfully used in several clinical trials using gene therapy to treat cardiovascular diseases and cancer. The vaccine uses a safe adenovirus carrier that contains a cloned DNA strand, which causes nasopharyngeal cells to produce the virus protein which, in turn, produces a response to the vaccine. There is no actual SARS-CoV-2 virus in the vaccine. Prelimin ....

Norra Savolax , United Kingdom , South Africa , Eteläuomen Läi , North Karelia , Landskapet Birkaland , South African , Kari Alitalo , University Of Helsinki , Rokote Laboratories Finland Ltd , Prnewswire Rokote Laboratories Finland Ltd , National Virus Vector Laboratory , Ai Virtanen Institute For Molecular , Academy Professor Seppo Yl , University Of Eastern Finland , Laboratories Finland Ltd , Eastern Finland , Virology Kalle Saksela , Rokote Laboratories Finland , Professor Kalle Saksela , Professor Kari Alitalo , ஒன்றுபட்டது கிஂக்டம் , வடக்கு கரேலியா , பல்கலைக்கழகம் ஆஃப் ஹெல்சின்கி , தேசிய வைரஸ் திசையன் ஆய்வகம் , பல்கலைக்கழகம் ஆஃப் கிழக்கு பின்லாந்து ,